Matches 1 - 50 out of 341 1 2 3 4 5 6 7 >
Match Document Document Title
7622506 Naphthalenedione compounds for treating inflammation related disorders and microbial infection  
This invention relates to compositions containing a compound of formula (I) shown below: Each variable is defined in the specification. Also disclosed are methods of using these compositions to...
7501455 Pharmaceutical compositions containing plasma protein  
The invention is related to water-soluble products and pharmaceutical formulations in solid or liquid form mainly for parenteral use. They consist of or comprise a therapeutically active substance...
7491847 Methods for isolating propargylated aminoindans  
A process for isolating from a reaction mixture a salt of a mono-propargylated aminoindan, a process for isolating from a reaction mixture a crystalline diastereomeric salt of a mono-propargylated...
7488753 Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof  
This invention provides composition comprising a triterpenoidal saponin, comprising two side groups attached to carbon 21, and 22 of triterpenoidal saponin backbone. This invention provides a...
7435756 Preparation and diabetic use of gibberellins  
The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of...
7435755 CDDO-compounds and combination therapies thereof  
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer...
7384977 Water soluble paclitaxel prodrugs  
Disclosed are water soluble compositions of paclitaxel and docetaxel formed by conjugating the paclitaxel or docetaxel to a water soluble polymer such as poly-glutamic acid, poly-aspartic acid or...
7378442 Chemical entities with multiple modes of anti-inflammatory action  
The invention relates to methods of treatment and pharmaceutical compositions of new chemical compounds that inhibit the various enzymes in the arachidonic acid pathway implicated in inflammatory...
7371780 Use of calphostin C to treat drug-resistant tumor cells  
Calphostin C is used to treat subjects for cancer which is resistant to treatment by other forms of chemotherapeutic drugs, for example breast or uterine cancer, or other cancers characterized by...
7314637 Method of administering liposomal encapsulated taxane  
Liposomal-encapsulated taxane or an antineoplastic derivative thereof or a mixture thereof is provided which is used to effect a therapeutically enhanced method of treating cancer. The liposomal...
7297691 Treatment of sleep disorders with cholinesterase inhibitors  
The present invention is concerned with treatment of sleep disorders by administering a cholinesterase inhibitor, and in particular, by administering galantamine or a pharmaceutically acceptable...
7268162 Aloe-emodin derivatives and their use in the treatment of neoplasias  
The invention relates to aloe-emodin (AE) derivatives and their use as anticancer drugs. Saids derivatives show a specific cytotoxicity to tumour cells, also of neuroectodermal origin, to which...
7196115 Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor  
The present invention relates to the bioactivity of taxanes isolated from the leaves of Himalayan Yew tree Taxus wallichiana against human cancer cell lines grown in-vitro and subsequent...
7160865 Cancer treatment including glycolytic inhibitors  
Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as...
7132403 Antihelminthic anthraquinones and method of use thereof  
Anthraquinones are described which are antihelminthic and in particular, are useful in compositions for inhibiting Schistosoma sp. in vitro or in vivo. The preferred anthraquinones have the...
7119124 Pharmaceutical compositions containing plasma protein  
The invention is related to water-soluble products and pharmaceutical formulations in solid or liquid form mainly for parenteral use. They consist of or comprise a therapeutically active substance...
7109206 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
7101909 Calcium channel drugs and uses  
Novel multibinding compounds are disclosed. The compounds of this invention comprise 2–10 ligands covalently connected, each of the ligands being capable of binding to a ligand binding site in a...
7081465 Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders  
This invention relates to novel {overscore (ω)}-substituted-naphthyloxy-amino alkanes, their preparation and use as antihyperglycemic agents and for the treatment and prevention of cardiovascular...
7041701 Triterpenoid derivatives  
The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof, in therapy. Preferably, the compound may be used for treating a patient...
7026355 Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases  
The present invention relates to the use of rhein or diacerhein compounds to treat and prevent vascular diseases that cause obstruction of the vascular system such as blood vessel restenosis and...
7015247 Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs  
Ibuprofen-aspirin compounds useful in treating aspirin or ibuprofen-treatable conditions, hydroxymethylacylfulvene analogs useful as antitumor drugs, and L-sugar illudin analogs useful as antitumor...
6984389 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality  
The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a...
6967218 Pravastatin pharmaceutical formulations and methods of their use  
The present invention relates to formulations comprising a therapeutically effective amount of pravastatin, or a pharmaceutically acceptable salt thereof, and methods of their use. The present...
6949557 Hydroanthracene based compounds as anticancer agents  
The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing...
6933291 Cholesterol lowering supplement  
The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as suitable composition comprising...
6916837 Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them  
Amidino derivatives represented by the following general formula (I): {where X is a group represented by R 1 SO 2 NR 2 — (wherein R 1 represents optionally substituted C 6-14 aryl, etc....
6903076 Antihelminthic anthraquinones and method of use thereof  
Anthraquinones are described which are antihelminthic and in particular, are useful in compositions for inhibiting Schistosoma sp. in vitro or in vivo. The preferred anthraquinones have the...
6897237 MMP-12 inhibitors  
A compound of the formula (I): wherein R 1 is hydroxy and the like; R 2 is optionally substituted lower alkyl and the like; R 3 is hydrogen atom and the like; R 4 is optionally substituted...
6890946 Use of parthenolide to inhibit cancer  
The invention provides a method comprising the use of parthenolide, including its analogs, to treat cancer or conditions characterized by abnormal angiogenesis.
6884817 Water soluble paclitaxel derivatives  
Disclosed are water soluble compositions of paclitaxel and docetaxel formed by conjugating the paclitaxel or docetaxel to a water soluble polymer such as poly-glutamic acid, poly-aspartic acid or...
6875746 Anticancer anthraquinones and method of use thereof  
Anthraquinones are described which have anticancer or antitumor activity and which are useful for inhibiting cancer cells and cells comprising tumors in vitro or in vivo. Preferably, the...
6872713 Antiprotozoal saponins  
Saponins of formula (I), a stereoisomeric form thereof or a pharmaceutically acceptable addition salt thereof, wherein R 1 to R 12 have the meaning given in the description, can be isolated from...
6826033 Aminoalcohol derivatives  
The present invention relates to a compound formula (I) wherein X 1 is bond or —O—CH 2 —, (II) or (III) R 1 is hydrogen or an amino protective group, a is phenyl, indolyl or carbazolyl,...
6822000 Bioerodible poly (orthoesters) from dioxolane-based diketene acetals  
Bioerodible poly(orthoesters) useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents contain hydrogen bonding groups and α-hydroxy...
6794409 Use of ERβ-selective ligands for regulating fertility and compounds useful therefor  
The present invention discloses the use of ERβ-selective ligands for production of medicaments for regulating fertility without additional use of a progestin. ERβ-agonists are used for treatment...
6790864 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs  
Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted...
6770676 Dicarboxylic acid derivatives  
The present invention relates to 2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives represented by the formula: the pharmaceutically acceptable salts thereof, or the hydrates...
6767920 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure  
The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective...
6727279 Arylsulphonamides and analogues  
The present invention relates to novel arylsulphonamides and analogues, to processes for their preparation and to their use for the prophylaxis and treatment of neurodegenerative disorders, in...
6689807 HMG CoA reductase inhibitors for promoting angiogenesis  
This invention relates to methods and compositions for the treatment of conditions associated with vascular insufficiency, and to methods and compositions for screening assays to select agents that...
6635672 Agent for lowering prolactin  
The present invention relates to a prolactin lowering drug containing at least one bicyclic diterpene of the labdane or clerodane type: wherein R1=H, C 1 to C 3 alkyl or C 1 to C 3 acyl.
6630502 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor  
A method is provided for slowing the progression of atherosclerosis in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients by administering a...
6624192 Process for production of diacetylrhein  
The present invention provides a process for obtaining diacetylrhein, wherein diacetylrhein containing aloe-emodin components is subjected to a liquid—liquid partitioning between a polar organic...
6607712 Composition and methods containing an antimicrobial essential oil extended from Coleus forskohlii  
An essential oil composition from Coleus forskohlii is used in compositions and methods for the treatment of skin infections and in the prevention and treatment of dental caries.
6596764 Method of preparing diacetyl rhein  
The present invention provides a process for treating arthritis utilizing substantially pure diacetylrhein having an aloe-emodin content of less than 20 ppm.
6593363 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same  
The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1).
6548534 Nonsteroidal gestagens  
This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar 1 , R 1 , R 2 and R 3 have the meanings that are indicated in more detail in the description....
6541515 HIV integrase inhibitors  
Compounds useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts,...
6521646 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis  
Compounds of the formula (I) and their physiologically acceptable salts and solvates are useful as integrin-inhibiting substances. They are especially useful in the prophylaxis and treatment of...
Matches 1 - 50 out of 341 1 2 3 4 5 6 7 >